Invesaro

Stocks TRAW Earnings

Earnings

Traws Pharma, Inc. (TRAW) earnings

Quarterly results of Traws Pharma, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when TRAW files with the SEC.

Next earnings date

Traws Pharma, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2025

In Q2 FY2025 (ended June 30, 2026) Traws Pharma, Inc. reported revenue of - and a net loss of $3.1M.

Diluted earnings per share were -$0.16.

Filed with the SEC on August 14, 2026.

Revenue by quarter
Q3 24: $57K $57K Q3 24Q4 24: $56K $56K Q4 24Q1 24: $57K $57K Q1 24Q2 24: $2.7M $2.7M Q2 24
Net income by quarter
Q3 24: -$8.5M -$8.5M Q3 24Q4 24: -$29.9M -$29.9M Q4 24Q1 24: $21.5M $21.5M Q1 24Q2 24: -$915K -$915K Q2 24Q3 24: -$4M -$4M Q3 24Q4 24: -$7.4M -$7.4M Q4 24Q1 25: -$7.1M -$7.1M Q1 25Q2 25: -$3.1M -$3.1M Q2 25

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2025June 30, 2026---$3.1M-$0.16
Q1 FY2025March 31, 2026---$7.1M-$0.53
Q4 FY2024December 31, 2025---$7.4M-
Q3 FY2024September 30, 2025---$4M-$0.34
Q2 FY2024June 30, 2025$2.7M--$915K-$0.11
Q1 FY2024March 31, 2025$57K-$21.5M$2.09
Q4 FY2024December 31, 2024$56K--$29.9M-
Q3 FY2024September 30, 2024$57K--$8.5M-$1.49

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Traws Pharma, Inc.'s next earnings date?

Traws Pharma, Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when TRAW reports

Follow TRAW and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when TRAW files with the SEC.

Source: quarterly figures Traws Pharma, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Traws Pharma, Inc.